Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Non-Hormonal Contraceptives Market Forecast: What Value Will The Market Reach By 2030?
The non-hormonal contraceptives market has seen significant expansion in recent years. Its valuation is predicted to rise from $25.47 billion in 2025 to $27.32 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.3%. The drivers behind its past growth include the initial limited availability of non-hormonal contraceptive methods, a historical reliance on surgical sterilization, increasing awareness surrounding reproductive health, the proliferation of female healthcare initiatives, and the adoption of barrier devices in clinical environments.
The non-hormonal contraceptives market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $35.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast timeframe is largely driven by factors such as the creation of sophisticated non-hormonal devices, an increasing call for reversible and less invasive sterilization options, the broadening scope of family planning initiatives, greater recognition of safety and compliance requirements, and the incorporation of intelligent contraceptive monitoring systems. Key trends anticipated during this period encompass a growing inclination towards non-hormonal birth control solutions, a wider uptake of barrier and mechanical contraceptives, enhanced understanding of reversible sterilization alternatives, the proliferation of minimally invasive contraceptive technologies, and a strong emphasis on ensuring safety, adherence, and a patient-focused design.
Get A Free Sample Report With In-Depth Market Insights:
Non-Hormonal Contraceptives Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing incidence of sexually transmitted diseases is projected to drive the expansion of the non-hormonal contraceptives market in the future. These infections, known as STDs, are primarily transmitted via sexual interaction and result from bacteria, viruses, or parasites. The rise in sexually transmitted diseases is largely due to reduced condom use, which elevates the risk of infection during unprotected sexual activity. Non-hormonal contraceptives, such as male and female condoms, play a crucial role in preventing STD transmission by acting as a physical barrier that stops the transfer of bodily fluids during sexual encounters. For example, the Minnesota Department of Health (MDH), a US-based state health agency, reported in April 2025 that the percentage of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024. Consequently, the increasing occurrence of sexually transmitted diseases is fueling the expansion of the non-hormonal contraceptives market.
Non-Hormonal Contraceptives Market Segment Performance And Emerging Opportunities
The non-hormonal contraceptives market covered in this report is segmented –
1) By Type: Devices, Sterilization, Other Product Types
2) By Mechanism Of Action: Antagonist, Agonist, Inhibitor, Modulator
3) By Route of Administration: Intramuscular, Intravaginal, Intravenous, Oral, Subcutaneous, Topical, Transdermal, Other Route Of Administrations
4) By Purpose Of Therapy: Treatment Of Disease, Management Of Symptoms
5) By Target Indication: Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis, Other Target Indications
Subsegments:
1) By Devices: Surgical Instruments, Ligation Clips, Tubal Rings
2) By Sterilization: Permanent Sterilization, Reversible Sterilization, Mechanical Sterilization Devices
3) By Other Product Types: Non-Surgical Barrier Devices, Implantable Plugs, Intrauterine Permanent Devices
Non-Hormonal Contraceptives Market Innovation Trends Shaping Future Development
Key players in the non-hormonal contraceptives market are directing their efforts towards creating advanced solutions, like preloaded intrauterine device delivery systems, to streamline insertion processes, increase user comfort, and boost clinical effectiveness. A preloaded intrauterine device (IUD) delivery system is characterized as a pre-constructed, immediately usable device where the intrauterine device and its inserter are combined into one unit. This design aims to simplify the insertion procedure, shorten preparation time, and decrease the potential for contamination or errors during handling. For example, in September 2024, CooperSurgical Inc., a US-based medical device and fertility company, launched the Paragard Single-Handed Inserter. This innovation is intended to improve insertion efficacy and overall patient comfort during the application of non-hormonal preloaded intrauterine devices. This product delivers highly effective, long-lasting birth control, offering over 99% effectiveness for up to 10 years by stopping sperm from fertilizing an egg. Its primary advantages include prompt and reversible contraception, its suitability as a hormone-free alternative, and requiring little maintenance after placement.
Non-Hormonal Contraceptives Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the non-hormonal contraceptives market are Church & Dwight Co., Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, Contraline Inc.
View The Full Non-Hormonal Contraceptives Market Report:
Non-Hormonal Contraceptives Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the non-hormonal contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-hormonal contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
